These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23113544)

  • 1. Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia.
    Lee TY; Ezelle HJ; Venkataraman T; Lapidus RG; Scheibner KA; Hassel BA
    J Interferon Cytokine Res; 2013 Jan; 33(1):34-42. PubMed ID: 23113544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
    Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
    Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein.
    Hershkovitz-Rokah O; Modai S; Pasmanik-Chor M; Toren A; Shomron N; Raanani P; Shpilberg O; Granot G
    Cancer Lett; 2015 Jan; 356(2 Pt B):597-605. PubMed ID: 25305453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitors by targeting pro-oncogenic anterior gradient 2.
    Pan B; Yang J; Wang X; Xu K; Ikezoe T
    Exp Hematol; 2018 Dec; 68():80-88.e2. PubMed ID: 30195077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML).
    Fei J; Li Y; Zhu X; Luo X
    PLoS One; 2012; 7(3):e32834. PubMed ID: 22442671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells.
    Maran A; Waller CF; Paranjape JM; Li G; Xiao W; Zhang K; Kalaycio ME; Maitra RK; Lichtin AE; Brugger W; Torrence PF; Silverman RH
    Blood; 1998 Dec; 92(11):4336-43. PubMed ID: 9834240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia.
    Xu C; Fu H; Gao L; Wang L; Wang W; Li J; Li Y; Dou L; Gao X; Luo X; Jing Y; Chim CS; Zheng X; Yu L
    Oncogene; 2014 Jan; 33(1):44-54. PubMed ID: 23208504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML.
    Zhao L; Shan Y; Liu B; Li Y; Jia L
    Cell Death Dis; 2017 May; 8(5):e2830. PubMed ID: 28542127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment.
    Hershkovitz-Rokah O; Modai S; Pasmanik-Chor M; Toren A; Shomron N; Raanani P; Shpilberg O; Granot G
    Cancer Lett; 2015 May; 360(2):245-56. PubMed ID: 25697481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
    Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
    BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation.
    Huang T; Fu Y; Wang S; Xu M; Yin X; Zhou M; Wang X; Chen C
    Biomed Pharmacother; 2019 Nov; 119():109413. PubMed ID: 31518872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-29b suppresses CML cell proliferation and induces apoptosis via regulation of BCR/ABL1 protein.
    Li Y; Wang H; Tao K; Xiao Q; Huang Z; Zhong L; Cao W; Wen J; Feng W
    Exp Cell Res; 2013 May; 319(8):1094-101. PubMed ID: 23428668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia.
    Xishan Z; Ziying L; Jing D; Gang L
    Sci Rep; 2015 Jul; 5():12460. PubMed ID: 26228085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human RNase L tunes gene expression by selectively destabilizing the microRNA-regulated transcriptome.
    Rath S; Donovan J; Whitney G; Chitrakar A; Wang W; Korennykh A
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15916-21. PubMed ID: 26668391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells.
    Venturini L; Battmer K; Castoldi M; Schultheis B; Hochhaus A; Muckenthaler MU; Ganser A; Eder M; Scherr M
    Blood; 2007 May; 109(10):4399-405. PubMed ID: 17284533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting cyclin B2.
    Li H; Tian X; Wang P; Huang M; Xu R; Nie T
    Cell Mol Biol Lett; 2019; 24():66. PubMed ID: 31844417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells.
    Salati S; Salvestrini V; Carretta C; Genovese E; Rontauroli S; Zini R; Rossi C; Ruberti S; Bianchi E; Barbieri G; Curti A; Castagnetti F; Gugliotta G; Rosti G; Bergamaschi M; Tafuri A; Tagliafico E; Lemoli R; Manfredini R
    Oncotarget; 2017 Jul; 8(30):49451-49469. PubMed ID: 28533480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proto-oncogene Pim-1 is a target of miR-33a.
    Thomas M; Lange-Grünweller K; Weirauch U; Gutsch D; Aigner A; Grünweller A; Hartmann RK
    Oncogene; 2012 Feb; 31(7):918-28. PubMed ID: 21743487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-124-3p/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML.
    Liu YX; Wang L; Liu WJ; Zhang HT; Xue JH; Zhang ZW; Gao CJ
    J Hematol Oncol; 2016 Aug; 9(1):69. PubMed ID: 27516205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin.
    Kaymaz BT; Cetintaş VB; Aktan C; Kosova B
    Tumour Biol; 2014 Sep; 35(9):8733-42. PubMed ID: 24870597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.